Skip to main content
Advanced Technical IVT

MH

Also written as: MH — Malignant Hyperthermia

Life-threatening genetic disorder triggered by certain anesthetic agents causing hypermetabolism and hyperthermia.

Full Definition

Malignant hyperthermia is a rare but potentially fatal genetic disorder of skeletal muscle that can be triggered by volatile anesthetic agents and succinylcholine. It is characterized by hypermetabolism, hyperthermia, muscle rigidity, and acidosis. Early recognition and treatment with dantrolene are crucial for patient survival. MH susceptibility is inherited in an autosomal dominant pattern, and family history screening is important in pediatric patients. All anesthesia locations must maintain MH crisis carts with appropriate medications and protocols.

Usage

Usage note: Always use 'MH' as the standard abbreviation in clinical documentation

In Context

  • "MH protocol was initiated when the patient developed unexpected tachycardia and rising end-tidal CO2." — Crisis management report
  • "The family history was positive for MH, requiring a trigger-free anesthetic technique." — Pre-anesthetic evaluation

Also known as

malignant hyperpyrexia

Don't confuse with

hyperthermia neuroleptic malignant syndrome

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON